Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,454
Closed -$1.52M 643
2024
Q1
$1.52M Sell
19,454
-13
-0.1% -$967 0.2% 121
2023
Q4
$1.39M Sell
19,467
-49
-0.3% -$3.41K 0.2% 122
2023
Q3
$1.35M Buy
19,516
+1,681
+9% +$127K 0.22% 115
2023
Q2
$1.44M Sell
17,835
-80
-0.4% -$6.54K 0.25% 107
2023
Q1
$1.45M Sell
17,915
-1,127
-6% -$90.7K 0.27% 104
2022
Q4
$1.43M Sell
19,042
-4,263
-18% -$304K 0.29% 100
2022
Q3
$1.5M Hold
23,305
0.32% 96
2022
Q2
$1.61M Buy
23,305
+155
+0.7% +$11.5K 0.29% 103
2022
Q1
$1.78M Sell
23,150
-114
-0.5% -$8.2K 0.28% 94
2021
Q4
$1.78M Buy
23,264
+450
+2% +$33.1K 0.25% 108
2021
Q3
$1.68M Buy
+22,814
New +$1.71M 0.26% 103

Other funds holding HOLX

BFSG LLC's HOLX Position: Q2 2024 in Review

BFSG LLC sold out of Hologic (HOLX) in Q2 2024, closing a stake of 19,454 shares — an estimated $1.52M sold.

BFSG LLC first reported a position in HOLX in Q3 2021 and held it in 11 quarters. The position peaked at $1.78M in Q4 2021. 702 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • BFSG LLC reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • BFSG LLC sold 19,454 Hologic shares in Q2 2024, an estimated $1.52M.
  • BFSG LLC first reported a position in Hologic in Q3 2021 and held it in 11 quarters.
  • BFSG LLC's Hologic position peaked at $1.78M in Q4 2021.
  • 702 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.